Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey

Examining the neutralizing capacity of monoclonal antibodies (MAbs) used to treat COVID-19, as well as antibodies recovered from unvaccinated, previously vaccinated, and infected individuals, against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) remains crit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathema, Barun, Chen, Liang, Wang, Pengfei, Cunningham, Marcus H., Mediavilla, Jose R., Chow, Kar Fai, Luo, Yang, Zhao, Yanan, Composto, Kaelea, Zuckerman, Jerry, Zody, Michael C., Wilson, Nancy, Lee, Annie, Oschwald, Dayna M., Liu, Lihong, Iketani, Sho, Germer, Soren, Fennessey, Samantha, Wang, Maple, Kramer, Yael, Toole, Patricia, Maniatis, Tom, Ho, David D., Perlin, David S., Kreiswirth, Barry N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600516/
https://www.ncbi.nlm.nih.gov/pubmed/35997285
http://dx.doi.org/10.1128/mbio.02141-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600516/
https://www.ncbi.nlm.nih.gov/pubmed/35997285
http://dx.doi.org/10.1128/mbio.02141-22

Ejemplares similares